Bone Biologics Corporation Stock
Equities
BBLG
US0980705018
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -14.55% | -2.08% | -58.41% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.65M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | -3 | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.35
x | P/E ratio 2025 * |
-0.39
x | Employees | 2 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.38% |
1 day | -14.55% | ||
1 week | -2.08% | ||
Current month | +20.40% | ||
1 month | +6.21% | ||
3 months | -51.48% | ||
6 months | -61.48% | ||
Current year | -58.41% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 15-08-16 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 11-12-31 |
Don Hankey
CHM | Chairman | 81 | 18-07-15 |
Robert Gagnon
BRD | Director/Board Member | 49 | Jan. 07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.88 | -14.55% | 241,247 |
24-05-16 | 2.2 | -3.08% | 82,083 |
24-05-15 | 2.27 | -1.30% | 855,061 |
24-05-14 | 2.3 | +21.05% | 288,558 |
24-05-13 | 1.9 | -1.04% | 10,640 |
Delayed Quote Nasdaq, May 17, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.41% | 1.65M | |
-5.10% | 11.34B | |
+4.02% | 9.11B | |
+38.12% | 5.53B | |
-23.70% | 4.61B | |
+8.55% | 3.45B | |
-6.44% | 2.87B | |
-5.85% | 2.1B | |
-11.84% | 2.08B | |
-23.36% | 1.78B |
- Stock Market
- Equities
- BBLG Stock